Evolution of malaria protein family offers new drug targets

Family of parasite proteins presents new potential malaria treatment target

Researchers have shown that the evolution of a family of exported proteins in the malaria-causing parasite Plasmodium falciparum enabled it to infect humans.

Evolution of malaria protein family offers new drug targets

Researchers from the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have shown that the evolution of a family of exported proteins in the malaria-causing parasite Plasmodium falciparum enabled it to infect humans.

Trace the Evolution of Malaria Parasite Proteins

Researchers at the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have discovered that the evolution of a family of exported proteins in the malaria-causing parasite Plasmodium falciparum allowed it to infect people.

New Potential Target to Treat Malaria

Researchers at the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have discovered that a family of proteins called FIKK kinases, found in the deadliest malaria-causing parasite, Plasmodium falciparum, could be a promising new target for treating malaria.  Malaria is a life-threatening disease caused by a parasite that is transmitted to humans by some mosquitoes. While malaria is found globally, over 90% of the…